In recent years, MDMA therapy has emerged as a potential psychiatric treatment in a ketamine clinic setting. Many patients have questions about whether it is appropriate for them as part of a structured mental health care plan by a psychiatrist. The following blog answers some of the most the common questions about MDMA therapy and what you can expect from the treatment process.
MDMA therapy, or MDMA-assisted therapy (MDMA-AT), refers to the clinically supervised use of 3,4-methylenedioxymethamphetamine, colloquially known as "ecstasy" or "molly," as part of a comprehensive treatment plan in psychotherapy. Unlike the recreational use of MDMA, this approach follows strict medical and ethical guidelines as laid out by the Food and Drug Administration (FDA). In research settings, the treatment is conducted under the care of a licensed psychiatrist and integrated into a broader psychotherapy treatment plan.
On a federal level, MDMA therapy is not legal for general medical use in the United States. Its use in psychotherapy is still being researched in clinical trials. In 2017, the FDA granted it "breakthrough therapy" designation for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), suggesting it may be approved for broader medical use in the future.
As of August 2024, the FDA advisory panel voted against approving MDMA-AT for PTSD and requested additional Phase 3 trials to understand its long-term effects and safety. This means that it is not yet approved for clinical usage and requires further research to address potential for misuse, standardized treatment protocols, and the psychological impacts of MDMA outside of controlled medical environments. At the end of the day, MDMA remains a Schedule I controlled substance.
Researchers have primarily researched MDMA therapy in the treatment of PTSD and MDD as part of a comprehensive treatment plan. However, they have also considered using MDMA therapy for those with complex trauma, treatment-resistant depression (TRD), and certain anxiety disorders. Before the clinical trial begins, the research team has each patient undergo a comprehensive assessment, including their mental health history, physical health, and current medications.
As explored in clinical trials, MDMA therapy consists of three distinct types of sessions: preparatory, MDMA, and integration sessions. Before the patient undergoes MDMA treatment, they undergo three 90-minute preparatory sessions to educate them about the treatment and build trust in the psychiatric team. They will also work with the psychiatrist to establish clear therapeutic goals.
Then, the patient will move into the active treatment phase. A course of treatment involves two to three MDMA sessions. Most of these treatments last 6-8 hours and are scheduled once a week for 1 month. MDMA sessions typically involve two doses. The first dose is a full dose of 75–125 mg (80–120 mg in the most recent Phase 3 clinical trials). A supplemental dose, half of the initial amount, is offered 90–120 minutes later based on the patient's tolerance and the psychiatrist's professional judgment.
After each MDMA session, the patient will participate in three 90-minute integration sessions for a total of six to nine integration sessions per course of treatment. The first integration session happens the morning after the MDMA session. Meanwhile, the second and third sessions followed at about one-week intervals before the next MDMA session.
In controlled research studies, patients undergoing MDMA therapy have mild to moderate side effects that do not last long after treatment. The most common side effects include:
It is important to note that MDMA therapy supervised by a licensed psychiatrist is different from taking MDMA recreationally. The potential benefits of MDMA for PTSD and MDD have been demonstrated when taken as directed during a course of psychotherapy.
Although both treatments are psychedelic medicines, MDMA therapy and ketamine treatment operate through different neurobiological mechanisms in the human brain. MDMA is a non-traditional psychedelic that primarily stimulates serotonin production. Meanwhile, ketamine targets the glutamate system, leading to rapid symptom relief.
Additionally, MDMA-AT emphasizes that patients engage more during the treatment session, as the open state produced by the medicine encourages them to challenge harmful memories. In contrast, ketamine therapy is quieter and more internal, offering more of a mental reset that allows patients to see and feel things that may have been inaccessible before. Another important distinction is that ketamine therapy is already FDA-approved for limited clinical usage, while MDMA therapy is still restricted to clinical research trials.
Do you have further questions about the future of MDMA therapy? The Future Psych Ketamine Clinics team is here to answer them. Call our Myrtle Beach office to learn more or to schedule a consultation.
Request an appointment here: https://mb.futurepsychsolutions.com or call Future Psych Ketamine Clinics at (843) 788-9718 for an appointment in our Myrtle Beach office.
Check out what others are saying about our services on Yelp: Mdma Therapy in Myrtle Beach, SC.
Anxiety disorders are mental illnesses that cause excessive, uncontrollable worry. They are the most common mental illnesses in the United States, affecting nearly 40 million people. Anxiety disorders can begin at any age and last for a lifetime if left untreated. It can be difficult for loved ones to understand what someone with anxiety is…
Living with an anxiety disorder is challenging, especially when you do not have the tools to manage it. Anxiety, in these cases, is more than a passing feeling; it can be all-consuming and lead to isolation. The longer it is left untreated, the more severe the condition can become. If you are looking for relief…
Adult psychiatry strives to limit the impact of mental disorders on patients’ day-to-day lives. Many disorders and concerns start gradually, then begin to affect sleep, relationships, and work performance. A psychiatrist uses clinical training to connect symptoms with an accurate diagnosis and a practical plan. In a ketamine clinic, adult psychiatry also includes access to…
office today.Request an appointment or call Future Psych Ketamine Clinics at 843-788-9718 for an appointment in our Myrtle Beach office.
Anxiety disorders are mental illnesses that cause excessive, uncontrollable worry. They are the most common…
Living with an anxiety disorder is challenging, especially when you do not have the tools…
Adult psychiatry treats a wide range of conditions, including those that affect mood, anxiety, trauma…
While there are many types of anxiety disorders, two of the most common are generalized…
Panic attacks are common among people living with anxiety disorders. These attacks happen even though…
Seeking treatment for an anxiety disorder is crucial in restoring and maintaining your mental health.…
